Research Articles
The Traffic Controller in Our Joints: How a Tiny Molecule Fuels Rheumatoid Arthritis
Explore how Chemokine Ligand 20 (CCL20) drives Rheumatoid Arthritis inflammation and how targeted DMARDs offer new treatment hope.
When TNF Inhibitors Stop Working: The Mystery of Secondary Loss of Response in Rheumatoid Arthritis
Exploring why TNF inhibitors lose effectiveness in rheumatoid arthritis patients and the scientific quest for answers.
The Cytokine Clue: How Two Tiny Proteins Predict Arthritis Damage
Discover how Interleukin-21 (IL-21) and Interleukin-23 (IL-23) serve as early predictors of joint damage in Rheumatoid Arthritis patients.
The 12-Week Window: How Early Treatment Response Predicts Future Joint Damage in Rheumatoid Arthritis
Discover how clinical activity after 12 weeks of treatment can predict joint destruction in rheumatoid arthritis patients two years later.
Cracking RA's Cellular Code: How T-Cell Tracking is Revolutionizing Rheumatoid Arthritis Treatment
Discover how T-cell repertoire profiling is transforming rheumatoid arthritis treatment through personalized medicine approaches and advanced immune system analysis.
The Silent Messenger: How Tiny Particles in Blood Accelerate Rheumatoid Arthritis Damage
Discover how plasma exosomal miR-92a contributes to bone destruction in rheumatoid arthritis through cellular communication and molecular mechanisms.